Chemodenervation of strabismic children: a 2- to 5-year follow-up study compared with shorter follow-up

To determine longer-term efficacy of botulinum treatment, the author examined 85 children younger than 14 years of age who had been treated from November 1982 to February 1984, comparing shorter follow-up (range, 6-24 months) with longer follow-up (range, 2-5.5 years) as of last examination before M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 1989-07, Vol.96 (7), p.931-934
1. Verfasser: MAGOON, E. H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 934
container_issue 7
container_start_page 931
container_title Ophthalmology (Rochester, Minn.)
container_volume 96
creator MAGOON, E. H
description To determine longer-term efficacy of botulinum treatment, the author examined 85 children younger than 14 years of age who had been treated from November 1982 to February 1984, comparing shorter follow-up (range, 6-24 months) with longer follow-up (range, 2-5.5 years) as of last examination before March 1988. Fifty esotropes meeting the 2-year criteria for follow-up had an average of 35 prism diopters (PD) before and 5 PD after treatment. Twelve exotropes averaged 30 and 5 PD. No long-term complications were discovered. The results are similar to the shorter follow-up and suggest that botulinum is effective in creating a 2- to 5-year stable improvement for strabismic children.
doi_str_mv 10.1016/S0161-6420(89)32777-1
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_2771359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2771359</sourcerecordid><originalsourceid>FETCH-LOGICAL-p150t-52d2158eb4a72b268f4fb54977255349da345faf1aa0fb8594c9d7baaa48b3ad3</originalsourceid><addsrcrecordid>eNpNz0tLxDAUBeAgyjiO_oSBLFzoIppn07qTwRcMuFDXw02T2EjblKTjMP_egoO4uXdxPg4chJaM3jDKitu36TBSSE6vyupacK01YUdozpSsiNRMHKP5HzlFZzl_UUqLQsgZmk2aCVXN0eeqcV20rnfpG8YQexw9zmMCE3IXalw3obXJ9XcYMCd4jFiRvYOEfWzbuCPbYdJbu8d17AZIzuJdGBucm5hG90-doxMPbXYXh79AH48P76tnsn59elndr8nAFB2J4pYzVTojQXPDi9JLb6ZBWnOlhKwsCKk8eAZAvSlVJevKagMAsjQCrFig5W_vsDWds5shhQ7SfnMYPOWXhxxyDa1P0Nch_zHNC6WkFj_G-WZ9</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chemodenervation of strabismic children: a 2- to 5-year follow-up study compared with shorter follow-up</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>MAGOON, E. H</creator><creatorcontrib>MAGOON, E. H</creatorcontrib><description>To determine longer-term efficacy of botulinum treatment, the author examined 85 children younger than 14 years of age who had been treated from November 1982 to February 1984, comparing shorter follow-up (range, 6-24 months) with longer follow-up (range, 2-5.5 years) as of last examination before March 1988. Fifty esotropes meeting the 2-year criteria for follow-up had an average of 35 prism diopters (PD) before and 5 PD after treatment. Twelve exotropes averaged 30 and 5 PD. No long-term complications were discovered. The results are similar to the shorter follow-up and suggest that botulinum is effective in creating a 2- to 5-year stable improvement for strabismic children.</description><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/S0161-6420(89)32777-1</identifier><identifier>PMID: 2771359</identifier><identifier>CODEN: OPHTDG</identifier><language>eng</language><publisher>New York, NY: Elsevier</publisher><subject>Adolescent ; Biological and medical sciences ; Botulinum Toxins - therapeutic use ; Child ; Child, Preschool ; Esotropia - therapy ; Follow-Up Studies ; Humans ; Infant ; Injections ; Longitudinal Studies ; Medical sciences ; Oculomotor disorders ; Oculomotor Muscles - innervation ; Ophthalmology ; Strabismus - therapy ; Visual Acuity</subject><ispartof>Ophthalmology (Rochester, Minn.), 1989-07, Vol.96 (7), p.931-934</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7265547$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2771359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MAGOON, E. H</creatorcontrib><title>Chemodenervation of strabismic children: a 2- to 5-year follow-up study compared with shorter follow-up</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>To determine longer-term efficacy of botulinum treatment, the author examined 85 children younger than 14 years of age who had been treated from November 1982 to February 1984, comparing shorter follow-up (range, 6-24 months) with longer follow-up (range, 2-5.5 years) as of last examination before March 1988. Fifty esotropes meeting the 2-year criteria for follow-up had an average of 35 prism diopters (PD) before and 5 PD after treatment. Twelve exotropes averaged 30 and 5 PD. No long-term complications were discovered. The results are similar to the shorter follow-up and suggest that botulinum is effective in creating a 2- to 5-year stable improvement for strabismic children.</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Botulinum Toxins - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Esotropia - therapy</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Infant</subject><subject>Injections</subject><subject>Longitudinal Studies</subject><subject>Medical sciences</subject><subject>Oculomotor disorders</subject><subject>Oculomotor Muscles - innervation</subject><subject>Ophthalmology</subject><subject>Strabismus - therapy</subject><subject>Visual Acuity</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNz0tLxDAUBeAgyjiO_oSBLFzoIppn07qTwRcMuFDXw02T2EjblKTjMP_egoO4uXdxPg4chJaM3jDKitu36TBSSE6vyupacK01YUdozpSsiNRMHKP5HzlFZzl_UUqLQsgZmk2aCVXN0eeqcV20rnfpG8YQexw9zmMCE3IXalw3obXJ9XcYMCd4jFiRvYOEfWzbuCPbYdJbu8d17AZIzuJdGBucm5hG90-doxMPbXYXh79AH48P76tnsn59elndr8nAFB2J4pYzVTojQXPDi9JLb6ZBWnOlhKwsCKk8eAZAvSlVJevKagMAsjQCrFig5W_vsDWds5shhQ7SfnMYPOWXhxxyDa1P0Nch_zHNC6WkFj_G-WZ9</recordid><startdate>198907</startdate><enddate>198907</enddate><creator>MAGOON, E. H</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>198907</creationdate><title>Chemodenervation of strabismic children: a 2- to 5-year follow-up study compared with shorter follow-up</title><author>MAGOON, E. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p150t-52d2158eb4a72b268f4fb54977255349da345faf1aa0fb8594c9d7baaa48b3ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Botulinum Toxins - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Esotropia - therapy</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Infant</topic><topic>Injections</topic><topic>Longitudinal Studies</topic><topic>Medical sciences</topic><topic>Oculomotor disorders</topic><topic>Oculomotor Muscles - innervation</topic><topic>Ophthalmology</topic><topic>Strabismus - therapy</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MAGOON, E. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MAGOON, E. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemodenervation of strabismic children: a 2- to 5-year follow-up study compared with shorter follow-up</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>1989-07</date><risdate>1989</risdate><volume>96</volume><issue>7</issue><spage>931</spage><epage>934</epage><pages>931-934</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><coden>OPHTDG</coden><abstract>To determine longer-term efficacy of botulinum treatment, the author examined 85 children younger than 14 years of age who had been treated from November 1982 to February 1984, comparing shorter follow-up (range, 6-24 months) with longer follow-up (range, 2-5.5 years) as of last examination before March 1988. Fifty esotropes meeting the 2-year criteria for follow-up had an average of 35 prism diopters (PD) before and 5 PD after treatment. Twelve exotropes averaged 30 and 5 PD. No long-term complications were discovered. The results are similar to the shorter follow-up and suggest that botulinum is effective in creating a 2- to 5-year stable improvement for strabismic children.</abstract><cop>New York, NY</cop><pub>Elsevier</pub><pmid>2771359</pmid><doi>10.1016/S0161-6420(89)32777-1</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0161-6420
ispartof Ophthalmology (Rochester, Minn.), 1989-07, Vol.96 (7), p.931-934
issn 0161-6420
1549-4713
language eng
recordid cdi_pubmed_primary_2771359
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Biological and medical sciences
Botulinum Toxins - therapeutic use
Child
Child, Preschool
Esotropia - therapy
Follow-Up Studies
Humans
Infant
Injections
Longitudinal Studies
Medical sciences
Oculomotor disorders
Oculomotor Muscles - innervation
Ophthalmology
Strabismus - therapy
Visual Acuity
title Chemodenervation of strabismic children: a 2- to 5-year follow-up study compared with shorter follow-up
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T09%3A05%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemodenervation%20of%20strabismic%20children:%20a%202-%20to%205-year%20follow-up%20study%20compared%20with%20shorter%20follow-up&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=MAGOON,%20E.%20H&rft.date=1989-07&rft.volume=96&rft.issue=7&rft.spage=931&rft.epage=934&rft.pages=931-934&rft.issn=0161-6420&rft.eissn=1549-4713&rft.coden=OPHTDG&rft_id=info:doi/10.1016/S0161-6420(89)32777-1&rft_dat=%3Cpubmed_pasca%3E2771359%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2771359&rfr_iscdi=true